ISMB 2026, Washington, D.C.
Nygen presents in the ISMB 2026 Tech Track. Parashar Dhapola, CEO, on leveraging LLMs for accurate and confidence-calibrated cell type and state identification.
Read more →Resources
A curated index of articles, updates, events, and published work across single-cell research.
The biology in your ligand-receptor analysis, and how to read it
Ligand-receptor analysis is easy to run and easy to over-read. How to get cell-cell communication biology from the ranked table, with LIANA and ScarfWeb.
Read more →
Johnson & Johnson R&D Symposium 2026, Beerse
Meet Nygen at the Johnson & Johnson R&D Symposium 2026 in Beerse, Belgium, June 18. Parashar Dhapola, CEO, will be on site for conversations on single-cell analytics and virtual biology for drug discovery.
Read more →
Drug Discovery Europe 2026, Berlin
Meet Nygen at Drug Discovery Europe 2026 in Berlin, June 15 to 16. Find us in the Data and AI Zone for conversations on single-cell analytics and AI for drug discovery.
Read more →
Cherry-picking is a bigger annotation risk than hallucination
Cherry-picking in LLM cell annotation survives reference checks unlike hallucination. Learn why biased marker subsampling is the harder risk and how CyteType prevents it.
Read more →
Festival of Genomics, Biodata & AI 2026, Boston
Nygen is an Agenda Partner at Festival of Genomics Boston 2026. Parashar Dhapola, CEO, presents on druggable cell populations missed by standard annotation on the Single-Cell Stage.
Read more →
Keystone Symposia: Computational Advances in Drug Discovery 2026
Nygen at Keystone Symposia Computational Advances in Drug Discovery in London, May 7 to 10, 2026. Short talk by Parashar Dhapola, CEO, on multi-agent AI for evidence-based cell type annotation.
Read more →
Global Innovation Summit 2026, Basel
Meet Nygen at the Global Innovation Summit 2026 in Basel on May 6. Constance Beyer, Fractional CBO, will be on site for partnering conversations on single-cell analytics and AI for drug discovery.
Read more →
Swiss Biotech Day 2026, Basel
Meet Nygen at Swiss Biotech Day 2026 in Basel on May 4 and 5. Constance Beyer, Fractional CBO, will be on site for partnering conversations on single-cell analytics and AI for drug discovery.
Read more →
25th BioPharma Drug Discovery Nexus 2026, Zurich
Nygen at the 25th BioPharma Drug Discovery Nexus in Zurich, April 29–30, 2026. Session with Parashar Dhapola on AI agents versus AI workflows for single-cell annotation at scale.
Read more →
QIAGEN Agentic AI and Data Innovation Summit 2026, Basel
Meet Nygen at the QIAGEN Agentic AI and Data Innovation Summit in Basel on April 22, 2026. Constance Beyer, Fractional CBO, will be on site for conversations on AI, knowledge graphs, and single-cell data for drug discovery.
Read more →
Beyond Biotech - the podcast from Labiotech
Parashar and Dylan discusses where AI truly delivers in biopharma, the persistent gaps in exploratory data analytics, and the critical bottlenecks in single-cell annotation. In a world abounding in AI hype, Parashar helps us cut through the noise and point out paths to data driven success.
Listen →
Everyone Is Building AI Agents for Drug Discovery. We Built a Workflow for One Task. Here's Why.
Why we rebuilt CyteType as a deterministic AI workflow instead of an agent, and why that distinction matters for production cell annotation pipelines.
Read more →
What We Got Wrong About AI Agents for Cell Annotation
Running CyteType's AI agents across thousands of single-cell RNA-seq datasets in production exposed run-to-run variance, selective evidence gathering, and inconsistent depth. We rebuilt cell type annotation as a deterministic LLM workflow for reproducible, auditable results in drug discovery pipelines.
Read more →
Accelerated Single-Cell Data Analysis | Free Course by Nygen
A free, hands-on single-cell RNA-seq course taught live in ScarfWeb. Go from raw count matrices to biologically interpretable results in under 3 hours, with CITE-seq and HTO upload supported where relevant.
View course →